Evaluation of the MAIIA dipstick test to detect recombinant human erythropoietin in plasma

Journal of Pharmaceutical and Biomedical Analysis

Volumn 67-68, Issue , 2012, Pages 123-128

  Ashenden, Michael ^a   Sharpe, Ken ^b   Garnham, Andrew ^c   Gore, Christopher J ^d,e  

^a SIAB Research consortium   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c DEAKIN UNIVERSITY   (Australia)

^d AUSTRALIAN INSTITUTE OF SPORT   (Australia)

^e FLINDERS UNIVERSITY   (Australia)

Author keywords

Blood doping; MAIIA; Recombinant human erythropoietin

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ADULT; ARTICLE; DOPING; DRUG BLOOD LEVEL; DRUG SCREENING; ELECTROPHORESIS; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; ERYTHROPOIETIN; HUMANS; LIMIT OF DETECTION; MALE; RECOMBINANT PROTEINS;

EID: 84862132396     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2012.04.025     Document Type: Article

References (14)

1. Lasne F., Martin L., Crepin N., de Ceaurriz J. Detection of isoelectric profiles of erythropoietin in urine: differentiation of natural and administered recombinant hormones. Anal. Biochem. 2002, 311:119-126.
2. Mallorqui J., Segura J., de Bolos C., Gutierrez-Gallego R., Pascual J.A. Recombinant erythropoietin found in seized blood bags from sportsmen. Haematologica 2008, 93:313-314.
3. Lasne F., Martin L., Martin J.A., de Ceaurriz J. Isoelectric profiles of human erythropoietin are different in serum and urine. Int. J. Biol. Macromol. 2007, 41:354-357.
4. Lonnberg M., Andren M., Birgegard G., Drevin M., Garle M., Carlsson J. Rapid detection of erythropoiesis-stimulating agents in urine and serum. Anal. Biochem. 2012, 420:101-114.
5. Franco Fraguas L., Carlsson J., Lonnberg M. Lectin affinity chromatography as a tool to differentiate endogenous and recombinant erythropoietins. J. Chromatogr. A 2008, 1212:82-88.
6. Lonnberg M., Andren M., Birgegard G., Garle M., Carlsson J. Proceedings of the 8th International Luebeck Conference on the Pathophysiology and Pharmacology of Erythropoietin and Other Hemopoietic Growth Factors 2009.
7. Ashenden M., Gough C.E., Garnham A., Gore C.J., Sharpe K. Current markers of the athlete blood passport do not flag microdose EPO doping. Eur. J. Appl. Physiol. 2011, 111:2307-2314.
8. R Development Core Team R: A Language and Environment for Statistical Computing 2003, R Foundation for Statistical Computing, Vienna.
9. Pinheiro J., Bates D., DebRoy S., Sarkar D. NLME: Linear and Nonlinear Mixed Effects Models. R Package Version 3. 1-96 2009, R Core Team, R Foundation for Statistical Computing.
10. Wide L., Bengtsson C. Molecular charge heterogeneity of human serum erythropoietin. Br. J. Haematol. 1990, 76:121-127.
11. World Anti-Doping Agency, Athlete Biological Passport Guidelines, (accessed: January 2012). http://www.wada-ama.org/en/Science-Medicine/Athlete-Biological-Passport/Operating-Guidelines/.
12. Sharpe K., Ashenden M.J., Schumacher Y.O. A third generation approach to detect erythropoietin abuse in athletes. Haematologica 2006, 91:356-363.
13. Halstenson C.E., Macres M., Katz S.A., Schneiders J.R., Watanabe M., Sobota J.T., Abraham P.A. Comparative pharmacokinetics and pharmacodynamics of epoetin alfa and epoetin beta. Clin. Pharmacol. Ther. 1991, 50:702-712.
14. Sottas P.E., Robinson N., Rabin O., Saugy M. The athlete biological passport. Clin. Chem. 2011, 57:969-976.